Register through Sept. 17 to receive the lowest rates for Advancing Gene + Cell Therapies for Cancer.
August 25, 2022
There are many routes for a gene therapy to be administered. During this Lunch & Learn, we break down the most common routes of gene therapy drug delivery and review the preclinical study model and how these routes are currently used in certain approved therapies or clinical trials.
Introduction Moderator: Vivian Fernandez, Executive Director of Patient Advocacy, REGENXBIO
Let’s Talk About Routes of Administration
Speaker: Kimberly Goodspeed, MD, Assistant Professor at UT Southwestern Medical School
Dr. Kimberly Goodspeed will give an overview of procedures, safety concerns, and limitations related to the application of different therapeutic delivery routes in humans. We will also discuss how these relate to delivery in animal models during preclinical studies. Attendees will learn about the use of certain routes for approved therapies or ongoing clinical trials, and what these differences mean for participants.
Moderated Q&A
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico